Loading clinical trials...
Loading clinical trials...
Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China
Conditions
Interventions
low-dose radiotherapy
Locations
1
China
Low-dose Radiotherapy and Neoadjuvant Chemotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma
Sichuan, Sichuan, China
Start Date
August 1, 2022
Primary Completion Date
July 1, 2023
Completion Date
July 1, 2023
Last Updated
August 17, 2022
NCT05860868
NCT05397769
NCT07177443
NCT06490341
NCT03604965
NCT01462474
Lead Sponsor
Sichuan Cancer Hospital and Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions